CS logo
small CS logo
Nippon Life Hospital

Osaka, Japan
General hospital in Osaka
2 Chome-1-54 Enokojima, Nishi Ward, Osaka, 550-0006

About Nippon Life Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Nippon Life Hospital


During the past decade, Nippon Life Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Nippon Life Hospital" #1 sponsor was "Amgen" with 3 trials, followed by "Bayer" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nippon Life Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Nippon Life Hospital


According to Clinical.Site data, the most researched conditions in "Nippon Life Hospital" are "Psoriasis" (5 trials), "Colorectal Cancer" (3 trials), "Anemia" (2 trials), "Plaque Psoriasis" (2 trials) and "Renal Insufficiency, Chronic" (2 trials). Many other conditions were trialed in "Nippon Life Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Nippon Life Hospital


Most popular intervention types in "Nippon Life Hospital" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apremilast" (4 trials), "Placebo" (3 trials), "BMS-986165" (2 trials), "Darbepoetin alfa" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Nippon Life Hospital


The vast majority of trials in "Nippon Life Hospital" are 14 trials for "All" genders.

Clinical Trials Status at Nippon Life Hospital


Currently, there are NaN active trials in "Nippon Life Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Nippon Life Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Nippon Life Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".